IL6 and vascular occlusion disorder: For example, the relationship between IL-6 and the activation of the NF-kB signalling pathway has been described, as well as the relationship between the risk of vascular occlusion and the action of this cytokine (64), an increase in lesions in the human blood-labyrinth barrier model (65) or even an improvement in inflammatory parameters when this IL-6 cytokine is blocked in animal models (66).